SCHEDULE: Susquehanna Group Boosts Medifast Stake to 6.0%
Beneficial Ownership Report Amendment
A group of Susquehanna-affiliated entities has reported a 6.0% beneficial ownership stake in Medifast, Inc., totaling 654,945 shares.
Summary
- G1 Execution Services, LLC, Susquehanna Fundamental Investments, LLC, and Susquehanna Securities, LLC, collectively referred to as the Reporting Persons, beneficially own 654,945 shares of Medifast, Inc. common stock.
- This aggregate ownership represents 6.0% of Medifast, Inc.'s outstanding common stock, based on 10,991,064 shares outstanding as of July 28, 2025.
- The beneficial ownership reported by Susquehanna Securities, LLC includes options to buy 613,400 shares.
- The Reporting Persons certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Medifast, Inc.
Sentiment
Score: 7
Explanation: The filing indicates a significant institutional stake by a reputable financial group, which is generally viewed positively as a sign of investor confidence, even if passive. No negative information is disclosed.
Positives
- Increased institutional ownership by a sophisticated financial group like Susquehanna may signal confidence in Medifast's long-term prospects.
- The acquisition is stated to be in the ordinary course of business, not for control, suggesting a passive investment interest rather than an activist stance.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding Medifast, Inc.'s future performance or operations.
Industry Context
This filing indicates a significant institutional investment in Medifast, Inc., a company operating in the health and wellness industry, specifically weight management and direct selling. Such an investment by a major financial group like Susquehanna could be interpreted as a vote of confidence in the company's business model or market position, potentially reflecting broader investor interest in the sector.
Comparison to Industry Standards
- This filing is an ownership disclosure and does not provide performance metrics for comparison to industry standards or specific comparable companies or projects. It solely reports the beneficial ownership stake of a financial group in Medifast, Inc.
Stakeholder Impact
- Shareholders: Increased institutional ownership may enhance market confidence and liquidity for Medifast, Inc. shares.
- Company Management: The presence of a significant institutional investor, even a passive one, may lead to increased scrutiny or engagement, though the filing disclaims intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 2025-07-28 | Date as of which Medifast, Inc. reported 10,991,064 shares outstanding in its Form 10-Q. |
| 2025-09-30 | Date of event which required the filing of this statement. |
| 2025-11-13 | Filing date of the Schedule 13G Amendment No. 1. |
Keywords
Medifast, MFA, Susquehanna, G1 Execution Services, Institutional Ownership, Schedule 13G, Beneficial Ownership, Common Stock, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.